Skip to main content
In stock | Radiopharmaceutical / Nuclear Medicine

Lutetium-177 Vipivotide Tetraxetan

Oncology Type Both (Solid & Hematologic)
Drug Class / Mechanism Radiotherapeutic / Radiodiagnostic Agent
No Image
Description

Lutetium-177 Vipivotide Tetraxetan is classified as a Radiotherapeutic / Radiodiagnostic Agent, sourced for use within our Radiopharmaceutical / Nuclear Medicine portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Radiopharmaceutical / Nuclear Medicine
Oncology Type Both (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3